Publications by authors named "Nathan Singh"

Claim this Profile
D
Diurnal Rhythm in Chimeric Antigen Receptor T-Cell Effectiveness in an Observational Study of 715 Patients.
Patrick G Lyons, Emily Gill, Prisha Kumar, Melissa Beasley, Brenna Park-Egan, Nathan Singh

JCI Insight· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disarming myeloid resistance in CAR T therapy.
John M Warrington, Nathan Singh

Cancer Cell· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal rhythms in chimeric antigen receptor T cell performance: an observational study of 670 patients.
Patrick G Lyons, Emily Gill, Prisha Kumar, Melissa Beasly, Brenna Park-Egan, Nathan Singh

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors.
Ju-Fang Chang, Jack H Landmann, Tien-Ching Chang, Mehmet Emrah Selli, Yangdon Tenzin, Nathan Singh

Cancer Discov· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approval of the first TCR-based cell therapy.
Nathan Singh

Mol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors.
Ju-Fang Chang, Nils Wellhausen, Nils W Engel, Jack H Landmann, Caitlin R Hopkins, Nathan Singh

Cancer Immunol Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Considerations for Genome-Edited T-cell Therapies.
Julie K Jadlowsky, Ju-Fang Chang, David H Spencer, John M Warrington, Bruce L Levine, Nathan Singh

Cancer Immunol Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of pre-treatment tumors reveals gatekeepers of response to CAR T cells.
Nathan Singh

Mol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic manipulation of the cancer-immunity cycle: CAR-T cell therapy.
Nathan Singh, Marcela V Maus

Immunity· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation.
Alexander B Kim, Ssu-Yu Chou, Solomon Kang, Eric Kwon, Matthew Inkman, Nathan Singh

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Nathan Singh

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, Sergio Bracarda, Joshua D Brody, Nathan Singh

J Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunction.
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, John Lattin, Amanda Heard, Nathan Singh

Blood· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures.
Mehmet Emrah Selli, Jack H Landmann, Corvin Arveseth, Nathan Singh

STAR Protoc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunction.
Mehmet Emrah Selli, Jack H Landmann, Marina Terekhova, John Lattin, Amanda Heard, Nathan Singh

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.
Armin Ghobadi, Jack H Landmann, Alun Carter, Matthew L Cooper, Mehmet Emrah Selli, Nathan Singh

Blood Adv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-specific depletion of CD4 T cells by CAR T cells reveals distinct roles of higher- and lower-affinity TCRs during autoimmunity.
Jaeu Yi, Aidan T Miller, Angela S Archambault, Andrew J Jones, Tara R Bradstreet, Nathan Singh

Sci Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19.
Amanda Heard, Jack H Landmann, Ava R Hansen, Alkmini Papadopolou, Yu-Sung Hsu, Nathan Singh

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies.
Sisi Zheng, Elisabeth Gillespie, Ammar S Naqvi, Katharina E Hayer, Zhiwei Ang, Nathan Singh

Blood Cancer Discov· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An NK-like CAR T cell transition in CAR T cell dysfunction.
Charly R Good, M Angela Aznar, Shunichiro Kuramitsu, Parisa Samareh, Sangya Agarwal, Nathan Singh

Cell· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modified T cells as therapeutic agents.
Nathan Singh

Hematology Am Soc Hematol Educ Program· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in CAR design.
Amanda Heard, Jufang Chang, John M Warrington, Nathan Singh

Best Pract Res Clin Haematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells.
Nathan Singh, Noelle V Frey, Boris Engels, David M Barrett, Olga Shestova

Nat Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.
Nathan Singh, Yong Gu Lee, Olga Shestova, Pranali Ravikumar, Katharina E Hayer

Cancer Discov· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Margaret M Billingsley, Nathan Singh, Pranali Ravikumar, Rui Zhang, Carl H June

Nano Lett· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis